Compare Biogen Inc (BIIB) vs Unilever plc (UL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Unilever plc — how do they compare? Biogen Inc trades at $204 (market cap $30.13B), while Unilever plc trades at $61.92 (market cap $134.06B). The key difference: Unilever plc is far larger — about 4.4× Biogen Inc's market cap, and Unilever plc pays a 3.65% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | UL | |
|---|---|---|
Market Cap | $30.13B | $134.06B |
Sector | Health | Consumer Staples |
52-Week High | $216.63 | $74.59 |
52-Week Low | $128.93 | $55.05 |
Enterprise Value | $37.20B | $159.86B |
Dividend Yield | — | 3.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Unilever plc
Unilever is a diversified personal product (42% of 2021 sales by value), home care (20%), and packaged food (38%) company. Its brands include Knorr soups and sauces, Hellmann's mayonnaise, Lipton teas, Axe and Dove skin products, and the TRESemme haircare brand. The firm has been acquisitive in recent years
Read more on UL →
